• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Tumor Multiplicity and Location Predict Bladder Inverted Papillary Tumor Recurrence

by
November 10, 2026
in Health
Reading Time: 2 mins read
0
Tumor Multiplicity and Location Predict Bladder Inverted Papillary Tumor Recurrence

Tumor Multiplicity and Location Predict Bladder Inverted Papillary Tumor Recurrence

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In patients with primary low-grade inverted papillary urothelial tumors of the bladder, tumor multiplicity and extra-trigonal location are stronger independent predictors of disease recurrence than histological classification. These findings stem from a study that evaluated clinicopathological features and identified prognostic factors for recurrence-free survival and progression-free survival following transurethral resection.

The single-center retrospective study evaluated a cohort of 286 patients treated with transurethral resection between 2009 and 2017. Within this cohort, 120 patients were diagnosed with inverted urothelial papilloma, 93 had inverted papillary urothelial neoplasms of low malignant potential, and 73 presented with low-grade inverted papillary urothelial carcinoma. Investigators evaluated clinicopathological features across these three diagnostic categories and analyzed survival outcomes using Kaplan–Meier methods and Cox regression.

Significant clinicopathological differences were observed when comparing patients with low-grade inverted papillary urothelial carcinoma to those with inverted urothelial papilloma or inverted papillary urothelial neoplasms of low malignant potential. Specifically, individuals with low-grade inverted papillary urothelial carcinoma were older and had larger tumors exceeding 1.5 centimeters in diameter. Furthermore, this patient group presented with more frequent multifocality and a higher frequency of extra-trigonal tumor locations, with all of these comparisons demonstrating statistical significance at P < 0.05.

Recurrence rates during postoperative follow-up varied across the histological subtypes, recorded at 0.8 percent for inverted urothelial papilloma, 6.5 percent for inverted papillary urothelial neoplasms of low malignant potential, and 9.6 percent for low-grade inverted papillary urothelial carcinoma. Overall, a total of 14 recurrence events were documented across the entire patient cohort.

In an exploratory multivariable Cox regression analysis, tumor multiplicity was independently associated with recurrence, yielding a hazard ratio of 6.23 with a 95 percent confidence interval of 2.06 to 18.85 (P = 0.001). Tumor location outside the bladder neck or trigone was also independently associated with recurrence, with a hazard ratio of 10.92 and a 95 percent confidence interval of 1.40 to 85.14 (P = 0.022). The authors highlighted that the wide confidence interval for tumor location reflects limited statistical precision, noting that the multivariable model was exploratory and requires further validation.

Disease progression occurred in 3.2 percent of patients with inverted papillary urothelial neoplasms of low malignant potential and 2.7 percent of those with low-grade inverted papillary urothelial carcinoma. An exploratory univariate analysis indicated that tumor multiplicity was associated with progression, showing a hazard ratio of 10.84 with a 95 percent confidence interval of 1.811 to 64.885 (P = 0.009). Because only five progression events occurred in the cohort, the authors emphasized that this finding is hypothesis-generating rather than an established prognostic factor, concluding that while easily obtained clinical parameters like multiplicity and tumor location may support practical risk stratification for postoperative surveillance, the findings require confirmation in larger cohorts.

Subject of Research: Prognostic factors for recurrence in low-grade bladder inverted papillary urothelial tumors

Article Title: The clinicopathologic spectrum and prognostic features of bladder inverted papillary tumors: a cohort of 286 patients

Article References: Wu, X., Weng, M., & Teng, X. (2026). The clinicopathologic spectrum and prognostic features of bladder inverted papillary tumors: a cohort of 286 patients. BMC Urology. https://doi.org/10.1186/s12894-026-02409-6

Image Credits: AI Generated

DOI: 10.1186/s12894-026-02409-6

Keywords: bladder cancer, urothelial tumors, inverted urothelial papilloma, tumor recurrence, urology, transurethral resection, oncology, clinicopathologic, spectrum, prognostic, features, bladder

News Source: Nathaniel Bowman. (November 10, 2026). Tumor Multiplicity and Location Predict Bladder Inverted Papillary Tumor Recurrence. Scienmag.

Tags: bladderbladder cancerClinicopathologicfeaturesinverted urothelial papillomaOncologyprognosticspectrumtransurethral resectiontumor recurrenceurologyurothelial tumors
Share12Tweet7Share2ShareShareShare1

Related Posts

Aortic Elongation Distinguishes Acute Dissection Risk Below Standard Diameter Thresholds

Aortic Elongation Distinguishes Acute Dissection Risk Below Standard Diameter Thresholds

November 17, 2026
Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

November 17, 2026

Retinal Imaging Detects Deep Foveal Avascular Zone Enlargement in Early Alzheimer’s Disease

November 17, 2026

Inhibiting EID1 Boosts Immune Cell Cooperation to Suppress Experimental Metastasis

November 17, 2026

POPULAR NEWS

  • Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    Mobile Health Units With Community Workers Address Critical Hypertension Care Gaps

    29 shares
    Share 12 Tweet 7
  • Brazilian EQ-5D Mapping Algorithm Offers Alternative to European-Based Standards

    29 shares
    Share 12 Tweet 7
  • Self-Assembled Berberine-Gallic Acid Nanorods Ameliorate Ulcerative Colitis in Mice

    29 shares
    Share 12 Tweet 7
  • Tablet Augmented Reality System May Reduce Preoperative Anxiety in Pediatric Surgical Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Aortic Elongation Distinguishes Acute Dissection Risk Below Standard Diameter Thresholds

Severe Early Infection Markers Linked to Rare Pediatric Post-Infectious Airway Obliteration

Retinal Imaging Detects Deep Foveal Avascular Zone Enlargement in Early Alzheimer’s Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.